| |
| |
|
| Insider
Information: |
Knappertz Volker |
| Relationship: |
EVP, Research and Deve... |
| City: |
Cambridge |
| State: |
X0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
319,128 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,566,918 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
319,128 |
|
|
| Total
Value |
$1,566,918 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -10.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gw Pharmaceuticals Plc |
GWPH |
Chief Medical Officer |
2021-05-05 |
0 |
2019-02-26 |
0 |
Premium* |
|
|
Aurinia Pharmaceuticals Inc |
AUPH |
EVP, Research and Deve... |
2024-02-27 |
319,128 |
2023-03-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AUPH |
Aurinia Pharmaceuticals I... |
EVP, Research and Development |
• – – |
2024-02-27 |
4 |
S |
$6.10 |
$30,073 |
D/D |
(4,930) |
319,128 |
0 |
% |
|
| AUPH |
Aurinia Pharmaceuticals I... |
EVP, Research and Development |
• – – |
2024-02-20 |
4 |
S |
$5.48 |
$137,800 |
D/D |
(25,146) |
324,058 |
0 |
% |
|
| AUPH |
Aurinia Pharmaceuticals I... |
EVP, Research and Development |
• – – |
2023-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
191,462 |
344,274 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Medical Officer |
• – – |
2021-05-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(92,412) |
0 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Director |
– • – |
2021-03-26 |
4 |
S |
$18.10 |
$55,386 |
D/D |
(3,060) |
92,412 |
0 |
% |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Medical Officer |
• – – |
2021-03-01 |
4 |
OE |
$0.00 |
$10 |
D/D |
6,864 |
98,184 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Medical Officer |
• – – |
2021-03-01 |
4 |
D |
$17.85 |
$48,409 |
D/D |
(2,712) |
95,472 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Medical Officer |
• – – |
2021-02-26 |
4 |
D |
$17.90 |
$852,326 |
D/D |
(47,616) |
91,320 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Medical Officer |
• – – |
2021-02-26 |
4 |
OE |
$0.00 |
$169 |
D/D |
120,996 |
94,645 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Medical Officer |
• – – |
2021-01-19 |
4 |
AS |
$11.67 |
$70,020 |
D/D |
(6,000) |
17,940 |
0 |
% |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Medical Officer |
• – – |
2020-11-24 |
4 |
AS |
$10.50 |
$126,000 |
D/D |
(12,000) |
23,940 |
0 |
% |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Medical Officer |
• – – |
2020-11-11 |
4 |
AS |
$10.00 |
$60,000 |
D/D |
(6,000) |
35,940 |
0 |
% |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Medical Officer |
• – – |
2020-11-04 |
4 |
AS |
$9.17 |
$55,020 |
D/D |
(6,000) |
41,940 |
0 |
% |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Medical Officer |
• – – |
2020-08-04 |
4 |
AS |
$11.11 |
$66,660 |
D/D |
(6,000) |
47,940 |
0 |
% |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Medical Officer |
• – – |
2020-07-20 |
4 |
AS |
$11.42 |
$68,520 |
D/D |
(6,000) |
53,940 |
0 |
% |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Medical Officer |
• – – |
2020-06-17 |
4 |
AS |
$10.35 |
$186,300 |
D/D |
(18,000) |
59,940 |
0 |
% |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Medical Officer |
• – – |
2020-05-18 |
4 |
D |
$9.67 |
$113,487 |
D/D |
(11,736) |
86,688 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Medical Officer |
• – – |
2020-05-18 |
4 |
OE |
$0.00 |
$160 |
D/D |
133,620 |
92,556 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Medical Officer |
• – – |
2020-03-02 |
4 |
S |
$8.32 |
$28,454 |
D/D |
(3,420) |
79,392 |
0 |
% |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Medical Officer |
• – – |
2020-02-26 |
4 |
S |
$9.17 |
$27,636 |
D/D |
(3,012) |
82,812 |
0 |
% |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Medical Officer |
• – – |
2019-05-20 |
4 |
S |
$14.52 |
$177,846 |
D/D |
(12,144) |
85,824 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Medical Officer |
• – – |
2019-05-18 |
4 |
OE |
$0.00 |
$16 |
D/D |
12,144 |
97,968 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Medical Officer |
• – – |
2019-05-15 |
4 |
AS |
$14.63 |
$62,850 |
D/D |
(4,296) |
77,940 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Medical Officer |
• – – |
2019-03-01 |
4 |
S |
$14.46 |
$53,965 |
D/D |
(3,732) |
8,736 |
0 |
- |
|
| GWPH |
Gw Pharmaceuticals Plc |
Chief Medical Officer |
• – – |
2019-02-26 |
4 |
S |
$12.29 |
$51,568 |
D/D |
(4,140) |
12,468 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
